Angiogenesis is a fundamental process of new blood vessel formation. It is critical for development, reproduction, and wound healing. Uncontrolled neovascularization plays a role in cancer, rheumatoid, vascular and other diseases. Angiogenesis is essential for providing oxygen and nutrients for tumor growth and for generating a gateway for cancer cell metastasis. Angiogenesis inhibitors may become one of the most promising types of drugs for starving tumor cells and preventing the spread of cancer cells. Angiogenesis involves proteolytic digestion of the extracellular matrix proteins such as collagens underlying the blood vessel endothelial cell layers. The long term goals of this research are to elucidate the mechanisms by which new blood vessels are formed, to identify the role of collagen-degrading matrixins (matrix metalloproteinases, MMPs) including membrane-type I matrix metalloproteinases, MMPs) including collagenases/gelatinases (MMP-2, MMP-9), and interstitial collagenase (MMP-1), in angiogenesis. The following two hypotheses will be tested. First, under angiogenic conditions, such as in the presence of vascular endothelial growth factor and/or basic fibroblast growth factor, endothelial cells will produce collagen degrading matrixins to break down type I and IV collagens. The role of each collagen-degrading matrixin in human microvascular endothelial cell -mediated collagen dissolution will be dissected with highly selective, potent, and novel synthetic inhibitors of matrixins. Second, collagen-degrading matrixins are required for angiogenesis and they may regulate endothelial cell proliferation, migration, and tube formation. The role of each collagen-degrading matrixin in each step of angiogenesis in vitro will be assessed through intervention by the synthetic matrixin inhibitors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA078646-04
Application #
6376888
Study Section
Pathology A Study Section (PTHA)
Program Officer
Ault, Grace S
Project Start
1998-07-01
Project End
2003-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
4
Fiscal Year
2001
Total Cost
$106,213
Indirect Cost
Name
Florida State University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
020520466
City
Tallahassee
State
FL
Country
United States
Zip Code
32306
Zhao, Yun-Ge; Xiao, Ai-Zhen; Ni, Jian et al. (2009) Expression of matrix metalloproteinase-26 in multiple human cancer tissues and smooth muscle cells. Ai Zheng 28:1168-75
Wildeboer, Dirk; Naus, Silvia; Amy Sang, Qing-Xiang et al. (2006) Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness. J Neuropathol Exp Neurol 65:516-27
Sang, Qing-Xiang Amy; Jin, Yonghao; Newcomer, Robert G et al. (2006) Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases. Curr Top Med Chem 6:289-316
Man, Yan-Gao; Shen, Ting; Zhao, Yunge et al. (2005) Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: A potential mechanism for basal cell layer disruptions and tumor invasion. Cancer Detect Prev 29:161-9
Hurst, Douglas R; Schwartz, Martin A; Jin, Yonghao et al. (2005) Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors. Biochem J 392:527-36
Qiu, Wei; Bai, Su-Xia; Zhao, Mei-Rong et al. (2005) Spatio-temporal expression of matrix metalloproteinase-26 in human placental trophoblasts and fetal red cells during normal placentation. Biol Reprod 72:954-9
Man, Yan-Gao; Shen, Ting; Weisz, Judith et al. (2005) A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion. Cancer Detect Prev 29:323-31
Hurst, Douglas R; Schwartz, Martin A; Ghaffari, Mohammad A et al. (2004) Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities. Biochem J 377:775-9
Man, Yan-Gao; Sang, Qing-Xiang Amy (2004) The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the ""protease-centered"" hypothesis. Exp Cell Res 301:103-18
Zhao, Yun-Ge; Xiao, Ai-Zhen; Park, Hyun I et al. (2004) Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion. Cancer Res 64:590-8

Showing the most recent 10 out of 31 publications